Abstract
Chromosomal aberrations, such as translocations or inversions, described for a growing number of malignancies, are now widely used to detect tumor cells by polymerase chain reaction (PCR). However, in multiple myeloma (MM), no such ubiquitous PCR marker exists. Therefore, other means have been established to distinguish myeloma cells from normal cells. Because the plasma cells of a myeloma clone share an identical rearranged immunoglobulin gene sequence, it is possible to detect malignant cells with PCR primers specific for the VDJ rearrangement of the heavy chain of each myeloma clone. The sensitivity and specificity of this method, named allele-specific oligonucleotide (ASO) PCR, even with low proportions of malignant cells, has been proven (1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cremer, F. W., Kiel, K., Wallmeier, M., Goldschmidt, H., and Moos, M. (1997) A quantitative PCR assay for the detection of low amounts of malignant cells in multiple myeloma. Ann. Oncol. 8, 633–636.
Tonegawa, S. (1983) Somatic generation of antibody diversity. Nature 302, 575–581.
Walter, M. A., Surti, U., Hofker, M. H., and Cox, D. W. (1990) The physical organisation of the human immunoglobulin heavy chain gene complex. Eur. Mol. Biol. Org. J. 9, 3303–3313.
Bakkus, M. H., Heirman, C., Van Riet, I., Van Camp, B., and Thielemans, K. (1992) Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood 80, 2326–2335.
Aubin, J., Davi, F., Nguyen-Salomon, F., Leboeuf, D., Debert, C., Taher, M., et al. (1995) Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia 9, 471–479.
Brisco, M. J., Tan, L. W., Orsborn, A. M., and Morley, A. A. (1990) Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population. Br. J. Haematol. 75, 163–167.
Campbell, M. J., Zelenetz, A. D., Levy, S., Levy, R. (1992) Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire. Mol. Immunol. 29, 193–203.
Deane, M., McCarthy, K. P., Wiedemann, I. M., and Norton, J. D. (1991) An improved method for detection of B-lymphoid clonality by polymerase chain reaction. Br. J. Haematol. 5, 726–730.
Diss, T. C., Peng, H., Wotherspoon, A. C., Isaacson, P. G., and Pan, L. (1993) Detection of monoclonality in low-grade β-cell lymphoma using the polymerase chain reaction is dependent on primer selection and lymphoma type. J. Pathol. 169, 291–295.
Moore, G. E. and Kitamura, H. (1968) Cell line derived from patient with myeloma. N. Y. State J. Med. 68, 2054–2060.
Klein, E., Klein, G., Nadkarmi, J. F., Nadkarmi, J. J., Vigzell, H., and Clifford, P. (1968) Surface IgM-k specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res. 28, 1300–1310.
Yamada, M., Wasserman, R., Reichard, B. A., Shane, S., Caton, A. J., and Rovera, G. (1991) Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J. Exp. Med. 173, 395–407.
Brisco, M. J., Condon, J., Sykes, P. J., Neoh, S. H., and Morley, A. A. (1991) Detection and quantitation of neoplastic cells in acute lymphoblastic leukaemia, by use of the polymerase chain reaction. Br. J. Haematol. 79, 211–217.
Wiesner, R. J. (1992) Direct quantitation of picomolar concentrations of mRNAs by mathematical analysis of a reverse transcription/exponential polymerase chain reaction assay. Nucleic Acids Res. 51, 5863–5864.
Taswell, C. (1981) Limiting dilution assays for the determination of immunocompetent cell frequencies. J. Immunol. 126, 1614–1619.
Cremer, F. W., Dada, R., Kiel, K., Ehrbrecht, E., Goldschmidt, H., and Moos, M. (1998) Quantitative PCR monitoring of the effect of double high-dose therapy on the tumor load of patients with multiple myeloma. Ann. Hematol. 77(Suppl. II), 182 (abstract 722).
Vescio, R. A., Han, E. J., Schiller, G. J., Lee, J. C., Wu, C. H., Cao, J., et al. (1996) Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts. Bone Marrow Transplant. 18, 103–110.
Cremer, F. W., Kiel, K., Wallmeier, M., Haas, R., Goldschmidt, H., and Moos, M. (1998) Leukapheresis products in multiple myeloma: lower tumor load after mobilization with cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) compared with G-CSF alone. Exp. Hematol. 26, 969–975.
Kiel, K., Cremer, F. W., Ehrbrecht, E., Wallmeier, M., Hegenbart, U., Goldschmidt, H., et al. (1998) First and second apheresis in patients with multiple myeloma: no differences in tumor load and hematopoietic stem cell yield. Bone Marrow Transplant. 21, 1109–1115.
Kiel, K., Cremer, F. W., Rottenburger, C., Kallmeyer, C., Ehrbrecht, E., Atzberger, A., et al. (1998) Circulating tumor cells in patients with multiple myeloma in the course of high-dose therapy. Ann. Hematol. 77(Suppl. II), 182 (abstract 724).
Rottenburger, C., Kiel, K., Cremer, F. W., B″sing, T., Atzberger, A., Moldenhauer, G., et al. (1998) No differences in the tumor load in the CD19+ and CD20+ cell fractions of peripheral blood from patients with multiple myeloma post high-dose therapy and with peripheral blood stem cell support. Ann. Hematol. 77(Suppl. II), 184 (abstract 731).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Cremer, F.W., Moos, M. (2003). Ultrasensitive PCR Detection of Tumor Cells in Myeloma. In: Bartlett, J.M.S., Stirling, D. (eds) PCR Protocols. Methods in Molecular Biology™, vol 226. Humana Press. https://doi.org/10.1385/1-59259-384-4:185
Download citation
DOI: https://doi.org/10.1385/1-59259-384-4:185
Publisher Name: Humana Press
Print ISBN: 978-0-89603-642-0
Online ISBN: 978-1-59259-384-2
eBook Packages: Springer Protocols